Pfizer and Bristol Myers have faced issues recently that have led to poor stock market performances. However, both drugmakers are spinning their innovative wheels and look likely to bounce back.
Bristol Myers (BMY) faces an uphill struggle as top drugs face challenges. We advise investors to steer clear for the time being.
24/7 Insights Dividend stocks offer investors the opportunity to increase investment total return.
In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $40.75, denoting a -0.9% change from the preceding trading day.
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Markets started the 2nd half of 2024 strong, with S&P up 1.69% and Nasdaq up 3.29%. Earnings season approaching, with the banking sector first, followed by the Magnificent Seven. Dividend Harvesting Portfolio hits all-time high, generating $44.41 in dividend income in the first week of July.
As the second half of 2024 unfolds, main Wall Street indices are reaching new highs. The Nasdaq 100 index soared more than 20% year-to-date, and the S&P 500 saw an all-time high with a 16% surge.
Bristol Myers Squibb upset investors with a big acquisition-related expense, but its pharmaceutical business is stronger than ever. Vici Properties is a real estate investment trust that collects rent from some of the largest casino operators in Las Vegas.
Dividend stocks for your July 2024 watchlist.
Despite markets reaching new heights recently, many defensive stocks with reliable and consistent demand are still experiencing their own market dip. They have pulled back as investors repositioned into the artificial intelligence (AI) trend.
24/7 Insights Wounded blue chip stocks can offer huge total return potential.
Bristol Myers Squibb has agreed to pay 10 million shekels ($2.7 million) in Israel to settle a potential case over its blocking of a generic version for anti-cancer drug Imnovid, Israel's Competition Authority said on Monday.